scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0264-410X(01)00497-2 |
P698 | PubMed publication ID | 11858861 |
P50 | author | Piet A van Rijn | Q41598182 |
René G.P.van Gennip | Q74520247 | ||
P2093 | author name string | A Bouma | |
R J M Moormann | |||
M N Widjojoatmodjo | |||
P2860 | cites work | Classical swine fever virus leader proteinase Npro is not required for viral replication in cell culture | Q27469566 |
Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines | Q27469643 | ||
cis- and trans-acting elements in flavivirus RNA replication | Q27469649 | ||
E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies | Q27469693 | ||
Cytopathogenicity of classical swine fever virus caused by defective interfering particles | Q27478476 | ||
Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins | Q27480305 | ||
Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity | Q27486161 | ||
Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera | Q27486212 | ||
Molecular characterization of pestiviruses | Q29620899 | ||
Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion | Q40063970 | ||
Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response | Q40613736 | ||
Development of a classical swine fever subunit marker vaccine and companion diagnostic test | Q40622391 | ||
Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristics | Q40624179 | ||
Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus | Q40628191 | ||
The classical swine fever epidemic 1997-1998 in The Netherlands: descriptive epidemiology | Q40628267 | ||
Classical swine fever in The Netherlands 1997-1998: a description of organisation and measures to eradicate the disease | Q40628272 | ||
Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus | Q40639488 | ||
Generation of cytopathogenic subgenomic RNA of classical swine fever virus in persistently infected porcine cell lines | Q40641197 | ||
Infection with classical swine fever virus: effects on phenotype and immune responsiveness of porcine T lymphocytes | Q40642235 | ||
An improved ELISA for the detection of serum antibodies directed against classical swine fever virus | Q40642253 | ||
Inhibition of pestivirus infection in cell culture by envelope proteins E(rns) and E2 of classical swine fever virus: E(rns) and E2 interact with different receptors | Q40644907 | ||
Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge | Q40662007 | ||
Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia | Q40712752 | ||
A preliminary map of epitopes on envelope glycoprotein E1 of HCV strain Brescia | Q40727836 | ||
Topographical and functional mapping of epitopes on hog cholera virus with monoclonal antibodies. | Q40770174 | ||
The protective value of vaccine-induced neutralising antibody titres in swine fever | Q40788758 | ||
Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis | Q40807127 | ||
Recovery of infectious classical swine fever virus (CSFV) from full-length genomic cDNA clones by a swine kidney cell line expressing bacteriophage T7 RNA polymerase. | Q40817409 | ||
The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus | Q40828304 | ||
Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. | Q40925612 | ||
An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV). | Q40967815 | ||
Isolation and characterization of cytopathogenic classical swine fever virus (CSFV). | Q42989784 | ||
Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine | Q45755044 | ||
P433 | issue | 11-12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | classical swine fever | Q19000581 |
P304 | page(s) | 1544-1556 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV | |
P478 | volume | 20 |
Q40447606 | A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)? |
Q39584650 | A mutant of Asia 1 serotype of Foot-and-mouth disease virus with the deletion of an important antigenic epitope in the 3A protein |
Q38736128 | Alteration of a Second Putative Fusion Peptide of Structural Glycoprotein E2 of Classical Swine Fever Virus Alters Virus Replication and Virulence in Swine |
Q47147214 | Animal health safety of fresh meat derived from pigs vaccinated against Classic Swine Fever |
Q36177381 | Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication |
Q40544173 | Attenuation of classical swine fever virus by deletion of the viral N(pro) gene |
Q35030911 | Beta-actin interacts with the E2 protein and is involved in the early replication of classical swine fever virus. |
Q40459043 | CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV). |
Q40289853 | Characterization of C-strain "Riems" TAV-epitope escape variants obtained through selective antibody pressure in cell culture |
Q39405057 | Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections |
Q40113607 | Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle |
Q38326027 | Classical swine fever in pigs: recent developments and future perspectives |
Q40073715 | Classical swine fever vaccines-State-of-the-art |
Q38294607 | Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge. |
Q35226312 | Classical swine fever--an update |
Q39489078 | Complementation studies with the novel "Bungowannah" virus provide new insights in the compatibility of pestivirus proteins |
Q40499628 | Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates |
Q47146243 | Control and eradication of Classic Swine Fever in wild boar |
Q40383594 | Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats. |
Q38989117 | Effect of specific amino acid substitutions in the putative fusion peptide of structural glycoprotein E2 on Classical Swine Fever Virus replication |
Q40428147 | Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus |
Q35865567 | Establishment and characterization of an infectious cDNA clone of a classical swine fever virus LOM strain |
Q39789272 | Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain |
Q36827352 | Hemoglobin subunit beta interacts with the capsid protein and antagonizes the growth of classical swine fever virus. |
Q40081087 | Identification and genetic characterization of classical swine fever virus isolates in Brazil: a new subgenotype. |
Q40472508 | Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus. |
Q58559646 | Identification of structural glycoprotein E2 domain critical to mediate replication of Classical Swine Fever Virus in SK6 cells |
Q39615889 | Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes |
Q40163067 | Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant |
Q35530213 | Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination |
Q39274226 | Interaction of CSFV E2 protein with swine host factors as detected by yeast two-hybrid system |
Q45378278 | Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion |
Q36578325 | Marker vaccine strategies and candidate CSFV marker vaccines |
Q40147986 | Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine. |
Q27478046 | N-Linked Glycosylation Status of Classical Swine Fever Virus Strain Brescia E2 Glycoprotein Influences Virulence in Swine |
Q34348810 | Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope |
Q36713635 | Novel marker vaccines against classical swine fever |
Q40510511 | Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. |
Q40125019 | Packaged replicons of bovine viral diarrhea virus are capable of inducing a protective immune response |
Q40409541 | Patterns of cellular gene expression in swine macrophages infected with highly virulent classical swine fever virus strain Brescia. |
Q40363429 | Patterns of gene expression in swine macrophages infected with classical swine fever virus detected by microarray. |
Q38266413 | RNA-based viral vectors |
Q36931230 | Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection |
Q40257221 | Sequencing approach to analyze the role of quasispecies for classical swine fever |
Q27469449 | The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine. |
Q40655799 | The envelope glycoprotein E2 is a determinant of cell culture tropism in ruminant pestiviruses |
Q35224851 | Time-calibrated phylogenomics of the classical swine fever viruses: genome-wide bayesian coalescent approach |
Q36177358 | Vaccination against classical swine fever virus: limitations and new strategies |
Q35576473 | Vaccinology of classical swine fever: from lab to field |